PL3099714T3 - Linia komórkowa hybrydomy (my-c-cc0c2-259-1 a4) i jej zastosowanie do wytwarzania przeciwciała monoklonalnego przeciwko ludzkiemu swoistemu dla serca białku c wiążącemu miozynę (białko c, mybpc3, cmybp-c lub my-c) - Google Patents
Linia komórkowa hybrydomy (my-c-cc0c2-259-1 a4) i jej zastosowanie do wytwarzania przeciwciała monoklonalnego przeciwko ludzkiemu swoistemu dla serca białku c wiążącemu miozynę (białko c, mybpc3, cmybp-c lub my-c)Info
- Publication number
- PL3099714T3 PL3099714T3 PL15713829T PL15713829T PL3099714T3 PL 3099714 T3 PL3099714 T3 PL 3099714T3 PL 15713829 T PL15713829 T PL 15713829T PL 15713829 T PL15713829 T PL 15713829T PL 3099714 T3 PL3099714 T3 PL 3099714T3
- Authority
- PL
- Poland
- Prior art keywords
- protein
- cc0c2
- cmybp
- mybpc3
- producing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4712—Muscle proteins, e.g. myosin, actin, protein
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102014000856.8A DE102014000856A1 (de) | 2014-01-27 | 2014-01-27 | Hybridom-Zelllinie (My-C-cC0C2-259-1A4) und deren Verwendung zur Herstellung eines monoklonalen Antikörpers gegen das humane, herzspezifische Myosin Binding Protein C (C-protein, MYBPC3, cMyBP-C oder My-C) |
| PCT/DE2015/000028 WO2015110114A2 (de) | 2014-01-27 | 2015-01-23 | Hybridom-zelllinie (my-c-cc0c2-259-1 a4) und deren verwendung zur herstellung eines monoklonalen antikörpers gegen das humane, herzspezifische myosin binding protein c (c-protein, mybpc3, cmybp-c oder my-c) |
| EP15713829.8A EP3099714B1 (de) | 2014-01-27 | 2015-01-23 | Hybridom-zelllinie (my-c-cc0c2-259-1 a4) und deren verwendung zur herstellung eines monoklonalen antikörpers gegen das humane, herzspezifische myosin binding protein c (c-protein, mybpc3, cmybp-c oder my-c) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3099714T3 true PL3099714T3 (pl) | 2022-01-03 |
Family
ID=52807462
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15713829T PL3099714T3 (pl) | 2014-01-27 | 2015-01-23 | Linia komórkowa hybrydomy (my-c-cc0c2-259-1 a4) i jej zastosowanie do wytwarzania przeciwciała monoklonalnego przeciwko ludzkiemu swoistemu dla serca białku c wiążącemu miozynę (białko c, mybpc3, cmybp-c lub my-c) |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10017745B2 (pl) |
| EP (1) | EP3099714B1 (pl) |
| JP (1) | JP6667443B2 (pl) |
| CN (1) | CN106459927B (pl) |
| CA (1) | CA2940505C (pl) |
| DE (2) | DE102014000856A1 (pl) |
| ES (1) | ES2879956T3 (pl) |
| PL (1) | PL3099714T3 (pl) |
| WO (1) | WO2015110114A2 (pl) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210247397A1 (en) * | 2018-06-07 | 2021-08-12 | Svar Life Science Ab | Complement c4d assay |
| WO2025027012A1 (en) | 2023-07-31 | 2025-02-06 | Roche Diagnostics Gmbh | Assay for mybpc3 |
| CN117517671A (zh) | 2023-07-31 | 2024-02-06 | 罗氏诊断有限公司 | 用于mybpc3的测定 |
| WO2025230857A1 (en) | 2024-05-01 | 2025-11-06 | Abbott Laboratories | Improved methods for determining cardiac myosin binding protein c in biological samples |
| CN119355275B (zh) * | 2024-10-28 | 2025-06-03 | 上海心妙生物科技有限公司 | 心肌肌球蛋白结合蛋白c检测试剂盒及其应用 |
| CN119841943B (zh) * | 2025-01-13 | 2025-09-16 | 厦门同仁心生物技术有限公司 | 一种抗ctnt的抗体对及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2829755B2 (ja) * | 1989-12-27 | 1998-12-02 | 株式会社第一ラジオアイソトープ研究所 | 抗ヒト心筋ｃプロテインモノクローナル抗体及び該抗体を産生するハイブリドーマ |
| WO2008104289A1 (en) * | 2007-02-27 | 2008-09-04 | Bayer Schering Pharma Aktiengesellschaft | Mybpc3 as a biomarker for ppara modulators |
| WO2009104289A1 (ja) * | 2008-02-19 | 2009-08-27 | Yamauchi Emiko | シネマライブ |
-
2014
- 2014-01-27 DE DE102014000856.8A patent/DE102014000856A1/de not_active Ceased
-
2015
- 2015-01-23 PL PL15713829T patent/PL3099714T3/pl unknown
- 2015-01-23 CN CN201580011262.0A patent/CN106459927B/zh active Active
- 2015-01-23 DE DE112015000507.2T patent/DE112015000507A5/de not_active Withdrawn
- 2015-01-23 EP EP15713829.8A patent/EP3099714B1/de active Active
- 2015-01-23 WO PCT/DE2015/000028 patent/WO2015110114A2/de not_active Ceased
- 2015-01-23 JP JP2016548721A patent/JP6667443B2/ja active Active
- 2015-01-23 US US15/114,670 patent/US10017745B2/en active Active
- 2015-01-23 CA CA2940505A patent/CA2940505C/en active Active
- 2015-01-23 ES ES15713829T patent/ES2879956T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3099714A2 (de) | 2016-12-07 |
| JP2017505618A (ja) | 2017-02-23 |
| ES2879956T3 (es) | 2021-11-23 |
| CN106459927B (zh) | 2020-03-17 |
| EP3099714B1 (de) | 2021-04-28 |
| CA2940505C (en) | 2022-08-02 |
| JP6667443B2 (ja) | 2020-03-18 |
| WO2015110114A2 (de) | 2015-07-30 |
| DE102014000856A1 (de) | 2015-07-30 |
| CA2940505A1 (en) | 2015-07-30 |
| CN106459927A (zh) | 2017-02-22 |
| WO2015110114A3 (de) | 2015-10-15 |
| DE112015000507A5 (de) | 2017-03-30 |
| US20170044501A1 (en) | 2017-02-16 |
| US10017745B2 (en) | 2018-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL270366A (en) | Anti-CD3 binding sites and antibodies containing them, and methods of making and using them | |
| IL274921A (en) | BCMA-directed chimeric antigen receptor and uses thereof | |
| LT3505535T (lt) | Monokloninis antikūnas prieš pd1, jo farmacinė kompozicija ir panaudojimas | |
| IL260218A (en) | Humanized monoclonal antibodies that elicit an immune response against interleukin-2, and their fusion proteins | |
| ZA201700528B (en) | Anti-ctla4 monoclonal antibody or antigen binding fragment thereof, medicinal composition and use | |
| SG10201911972QA (en) | Antibodies against tim3 and uses thereof | |
| ZA201608305B (en) | Monoclonal antibodies against her2 epitope and methods of use thereof | |
| LT3370768T (lt) | Antikūnai, specifiškai surišantys pd-1, ir jų panaudojimas | |
| IL274121A (en) | Bispecific antibodies that bind ALK-1 and BMPR-2 | |
| IL276746A (en) | Kir3dl3 as hhla2 receptor, anti-hhla2 antibodies and their uses | |
| EP3233916A4 (en) | Humanized anti-acth antibodies and use thereof | |
| ZA202003858B (en) | Monoclonal antibodies and methods for using same | |
| PL3099714T3 (pl) | Linia komórkowa hybrydomy (my-c-cc0c2-259-1 a4) i jej zastosowanie do wytwarzania przeciwciała monoklonalnego przeciwko ludzkiemu swoistemu dla serca białku c wiążącemu miozynę (białko c, mybpc3, cmybp-c lub my-c) | |
| SG11202012148RA (en) | Monoclonal antibodies against human tim-3 | |
| DE112015000512A5 (de) | Hybridom-Zelllinie (My-C-cC0C2-235-3H8) und deren Verwendung zur Herstellung eines monoklonalen Antikörpers gegen das humane, herzspezifische Myosin Bindung Protein C (C-protein), MYBPC3, cMyBP-C oder My-C) | |
| EP3590964A4 (en) | IMPROVED MONOCLONAL ANTI-VEGFR-2 ANTIBODY | |
| EP3177320A4 (en) | Human monoclonal antibodies against epha4 and their use | |
| IL267271A (en) | Antibodies against il-5 | |
| LT3390450T (lt) | Antii-cd28 humanizuoti antikūnai, paruošti vartoti žmonėms | |
| EP3095796A4 (en) | Anti-human probdnf monoclonal antibody, and uses thereof in pains | |
| IL272733A (en) | Monoclonal antibodies against pathological alpha-synuclein, and methods using same | |
| PL3845521T3 (pl) | Sposoby syntezy upadacytynibu i jego produktów pośrednich | |
| SI3269735T1 (sl) | Protitelo proti sklerostinu, antigen-vezavni fragment in medicinska uporaba le-tega | |
| EP3209686A4 (en) | Monoclonal anti-gpc-1 antibodies and uses thereof | |
| EP3211080A4 (en) | ANTI HUMAN Gas6 MONOCLONAL ANTIBODY |